Stanford Chronic Fatigue InitiativeAn initiative dedicated to studying infection-associated chronic diseases Mission StatementTo become a center of excellence that improves the health of patients with chronic diseases in which infection or its immune response plays a major etiologic role. To provide leadership, facilitate multidisciplinary collaboration, make new discoveries, and educate in the field of infection-associated chronic diseases. AimOur primary aim is to study the roles that infection and the immune response play in the symptoms of patients suffering from chronic, unexplained diseases. Recent News Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study. (please note this link will direct you to a webpage unaffiliated with Stanford University) Stanford Medical Minutes with Dr. Jose Montoya (please note this link will direct you to the Stanford University YouTube.com page) Presentation by Dr. Jose Montoya, given March 3, 2011, on Chronic Fatigue Syndrome at the Stanford University Frances C. Arrillaga Alumni Center (please note this link will direct you to the Stanford University YouTube.com page) |
Current Areas of Study
Infection-associated chronic diseases that our group studies include Chronic Fatigue Syndrome, Chronic Lyme Disease, Epilepsy, Multiple Sclerosis, and other unexplained chronic illnesses. We are interested in learning more about how infectious agents may play an etiologic role in these diseases. These infectious agents include human herpesvirus-6 (HHV-6), retroviruses such as xenotropic murine leukemia virus-related virus (XMRV), parasites such as Toxoplasma gondii, fungi such as Coccidiodes immitis, and bacteria such as Borrelia burgdorferi (the cause of Lyme disease).
|
|
